ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Tetrabutylammonium Hydroxide → 4-(2-Hydroxy-2-(4-(5-(5-phenyl-4-propylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)piperazine-2-carboxylic acid

HRID 1948501
印刷

反応式

HRID 1948501 の反応式
[C:1]([CH:4]1[CH2:9][NH:8][CH2:7][CH2:6][NH:5]1)([OH:3])=[O:2].[OH-].C([N+](CCCC)(CCCC)CCCC)CCC.Br[CH2:29][CH:30]([C:32]1[CH:37]=[CH:36][C:35]([C:38]2[N:42]=[C:41]([C:43]3[C:47]([CH2:48][CH2:49][CH3:50])=[C:46]([C:51]4[CH:56]=[CH:55][CH:54]=[CH:53][CH:52]=4)[O:45][N:44]=3)[O:40][N:39]=2)=[CH:34][CH:33]=1)[OH:31].CCN(C(N1N=NN(C2C(Cl)=CC=CC=2)C1=O)=O)C1CCCCC1>CS(C)=O.CO>[OH:31][CH:30]([C:32]1[CH:37]=[CH:36][C:35]([C:38]2[N:42]=[C:41]([C:43]3[C:47]([CH2:48][CH2:49][CH3:50])=[C:46]([C:51]4[CH:52]=[CH:53][CH:54]=[CH:55][CH:56]=4)[O:45][N:44]=3)[O:40][N:39]=2)=[CH:34][CH:33]=1)[CH2:29][N:8]1[CH2:7][CH2:6][NH:5][CH:4]([C:1]([OH:3])=[O:2])[CH2:9]1
参加物実験手順後処理出典と根拠反応ノート

参加物

7

反応物 4

HCID 2723671Tetrabutylammonium HydroxideHCID 2723758Piperazine-2-carboxylic acidHCID 3081363FentrazamideHCID 583740872-Bromo-1-(4-(5-(5-phenyl-4-propylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)phenyl)ethanol

生成物 1

HCID 509234234-(2-Hydroxy-2-(4-(5-(5-phenyl-4-propylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)piperazine-2-carboxylic acid

試薬・触媒・溶媒 2

HCID 679Dimethyl Sulfoxide溶媒2 回HCID 887Methanol溶媒

実験手順

To a solution of 2-carboxypiperazine (47 mg, 0.36 mmol) in 0.5 mL dry DMSO was added tetrabutylammonium hydroxide (0.360 mL, 360 μmol, 1M in THF) and the reaction mixture was stirred at rt for 15 min. 2-bromo-1-(4-(5-(5-phenyl-4-propylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)phenyl)ethanol, Preparation 1C (30 mg, 0.066 mmol) was dissolved in 0.5 mL DMSO and added and the reaction was agitated at 400 rpm on an INNOVA® platform shaker at 80° C. for 1.5 hours. The reaction was diluted with 250 μL of MeOH and purified by HPLC (MeOH—H2O-TFA) to give 4-(2-hydroxy-2-(4-(5-(5-phenyl-4-propylisoxazol-3-yl)-1,2,4-oxadiazol-3-yl)phenyl)ethyl)piperazine-2-carboxylic acid. MS (m+1)=504. HPLC RT=2.06 min Waters Masslynx instrument equipped with a 19×100 mm 5 uM C18 column and a method of 0-100% B solvent over 15 min at a flow rate of 20 mL/min. Solvent A is 5:95 acetonitrile/water; solvent B is 95:5 acetonitrile/water and both contain 0.5% TFA.

後処理

  1. additionadded
  2. custompurified by HPLC (MeOH—H2O-TFA)

出典と根拠

ORDレコード
ord-9929bb60b8da43ec9458c1df94f77ad8
出典データセット
uspto-grants-2013_03
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08399451B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート